Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the UK / NCT05110989
Recruiting Observational

A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

NCT05110989 · tracked via the Priya Life Science UK tracker
Sponsor
AtriCure, Inc
Phase
Observational
Started
2018-06-29
Last updated
2026-06-29

Condition(s) studied

Post Operative Pain

Investigational drug(s) / intervention(s)

AtriCure Cryo Nerve Block (cryoNB) Device Family

AtriCure Cryo Nerve Block (cryoNB) Device Family: Use of Atricure Cryo Nerve Block Device Family to generate cryoanalgesia for the management of post operative pain.

Study summary

This is a retrospective and prospective, multicenter, observational patient registry to record outcomes from patients undergoing cryoablation of the intercostal nerves (cryoanalgesia) for post-operative pain management.

Eligibility

Sex
ALL
Min age
12 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients whose age is 12 years or above, and are able to give informed consent/assent specific to state and national law. 2. Patients have been scheduled by physician(s) to undergo or have undergone cryoablation of the intercostal nerves utilizing at least one AtriCure device or are similar patients treated without the use of cryoablation Exclusion Criteria: 1. Patient is enrolled in a concurrent trial that may impact the treatment offered by the registry devices. 2. Patient with exclusion criteria required by local governance. 3. Women of childbearing potential who are, or plan to become, pregnant during the time of the study

Primary outcome measure(s)

  • Efficacy of cryo nerve block to generate cryoanalgesia as post operative pain management — From enrollment to 5 years after date of index procedure
    Collect pain score to assess the effect of cryoanalgesia effect with a follow up duration of up to 5 years.
  • Safety of cryo nerve block to generate cryoanalgesia as post operative pain management — From enrollment to 5 years after date of index procedure
    Collect adverse events occurred during and post operation to assess the safety of the cryo nerve block procedure.

Trial sites (11)

FacilityCityRegionStatus
Baptist MD Anderson Cancer Center Jacksonville Florida Recruiting
AdventHealth Orlando Florida Recruiting
Luminis Health Anne Arundel Medical Center Annapolis Maryland Recruiting
St. Luke's Hospital of Kansas City Kansas City Missouri Completed
Elliot Hospital Manchester New Hampshire Recruiting
The Christ Hospital Cincinnati Ohio Recruiting
Baylor College of Medicine Houston Texas Recruiting
Medical University of Vienna Vienna Austria Recruiting
UZ Leuven Leuven Belgium Recruiting
University of Heidelberg Heidelberg Germany Recruiting
University Hospitals Leicester NHS Trust Leicester United Kingdom Recruiting

More AtriCure, Inc. trials in the UK

HEAL-IST IDE Trial Active, not recruiting
CONVERGE Post-Approval Study (PAS) Active, not recruiting
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05110989 on ClinicalTrials.gov ↗ ← All trials in the UK